{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T06:11:26Z","timestamp":1794204686704,"version":"4.8.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01867-w","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T05:01:22Z","timestamp":1761368482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Function of p53 in angiogenesis and oxidative stress in rheumatoid arthritis"],"prefix":"10.1007","volume":"25","author":[{"given":"Behrouz","family":"Robat-Jazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maassoumeh","family":"Akhlaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash Sharafat","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"issue":"10","key":"1867_CR1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrrheum.2009.180","volume":"5","author":"CM Weyand","year":"2009","unstructured":"Weyand CM, Fujii H, Shao L, Goronzy JJ. Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol. 2009;5(10):583\u20138.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1867_CR2","volume":"13","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Liu L, Ti H, Chen M, Chen Y, Du D, et al. Synovial fibroblast derived small extracellular vesicles miRNA15-29148 promotes articular chondrocyte apoptosis in rheumatoid arthritis. Bone Res. 2025;13(1):61.","journal-title":"Bone Res"},{"issue":"11","key":"1867_CR3","volume":"10","author":"A-F Radu","year":"2021","unstructured":"Radu A-F, Bungau SG. Management of rheumatoid arthritis: an overview. Cells. 2021;10(11):2857.","journal-title":"Cells"},{"issue":"9","key":"1867_CR4","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1867_CR5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.berh.2010.10.001","volume":"24","author":"L Carmona","year":"2010","unstructured":"Carmona L, Cross M, Williams B, Lassere M, March L. Rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2010;24(6):733\u201345.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"1867_CR6","first-page":"e19432","volume":"13","author":"DT Fuller","year":"2021","unstructured":"Fuller DT, Kedar E, Lovelett CR, Mondal S, Sur S. Prevalence of common comorbidities in rheumatoid arthritis in rural New York compared with national data. Cureus. 2021;13(11):e19432.","journal-title":"Cureus"},{"issue":"1","key":"1867_CR7","volume":"20","author":"L Zhang","year":"2025","unstructured":"Zhang L, Luo Y, Shen HL. Enhancing the effectiveness of immunotherapy in rheumatoid arthritis by delaying immunosenescence triggered by fibroblast-like synoviocytes. J Orthop Surg Res. 2025;20(1):87.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"1867_CR8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233\u201355.","journal-title":"Immunol Rev"},{"key":"1867_CR9","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102304","volume":"67","author":"V Tsaltskan","year":"2022","unstructured":"Tsaltskan V, Firestein GS. Targeting fibroblast-like synoviocytes in rheumatoid arthritis. Curr Opin Pharmacol. 2022;67:102304.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"1867_CR10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"CM Weyand","year":"2021","unstructured":"Weyand CM, Goronzy JJ. The immunology of rheumatoid arthritis. Nat Immunol. 2021;22(1):10\u20138.","journal-title":"Nat Immunol"},{"issue":"11","key":"1867_CR11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/art.1780391103","volume":"39","author":"GS Firestein","year":"1996","unstructured":"Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthrit Rheum. 1996;39(11):1781\u201390.","journal-title":"Arthrit Rheum"},{"issue":"12","key":"1867_CR12","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm.2050","volume":"15","author":"S Lef\u00e8vre","year":"2009","unstructured":"Lef\u00e8vre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med. 2009;15(12):1414\u201320.","journal-title":"Nat Med"},{"issue":"5","key":"1867_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/ar113","volume":"2","author":"T Pap","year":"2000","unstructured":"Pap T, M\u00fcller-Ladner U, Gay RE, Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000;2(5):361\u20137.","journal-title":"Arthritis Res"},{"issue":"10","key":"1867_CR14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2011.04.020","volume":"10","author":"A Marrelli","year":"2011","unstructured":"Marrelli A, Cipriani P, Liakouli V, Carubbi F, Perricone C, Perricone R, et al. Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? Autoimmun Rev. 2011;10(10):595\u20138.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1867_CR15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/157339708786263942","volume":"4","author":"Z Szekanecz","year":"2008","unstructured":"Szekanecz Z, Koch AE. Targeting angiogenesis in rheumatoid arthritis. Curr Rheumatol Rev. 2008;4(4):298\u2013303.","journal-title":"Curr Rheumatol Rev"},{"key":"1867_CR16","volume":"27","author":"S Yue","year":"2025","unstructured":"Yue S, Fan J, Xie D, Cao C, Wang Z, Huang J, et al. Unveiling the therapeutic potential: targeting fibroblast-like synoviocytes in rheumatoid arthritis. Expert Rev Mol Med. 2025;27:e18.","journal-title":"Expert Rev Mol Med"},{"issue":"6","key":"1867_CR17","volume":"1879","author":"A Chen","year":"2024","unstructured":"Chen A, Huang H, Fang S, Hang Q. ROS: A \u201cbooster\u201d for chronic inflammation and tumor metastasis. Biochimica et Biophysica Acta (BBA). 2024;1879(6):189175.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"1867_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091263","author":"HR Lee","year":"2023","unstructured":"Lee HR, Yoo SJ, Kim J, Kang SW. LKB1 regulates inflammation of fibroblast-like synoviocytes from patients with rheumatoid arthritis via AMPK-dependent SLC7A11-NOX4-ROS signaling. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12091263.","journal-title":"Cells"},{"issue":"1","key":"1867_CR19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13075-020-02204-0","volume":"22","author":"HR Lee","year":"2020","unstructured":"Lee HR, Yoo SJ, Kim J, Yoo IS, Park CK, Kang SW. The effect of nicotinamide adenine dinucleotide phosphate oxidase 4 on migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther. 2020;22(1):116.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1867_CR20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/apha.12625","volume":"216","author":"V Helfinger","year":"2016","unstructured":"Helfinger V, Henke N, Harenkamp S, Walter M, Epah J, Penski C, et al. The NADPH oxidase Nox4 mediates tumour angiogenesis. Acta Physiol (Oxf). 2016;216(4):435\u201346.","journal-title":"Acta Physiol (Oxf)"},{"issue":"18","key":"1867_CR21","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1111\/febs.16110","volume":"289","author":"V Manuelli","year":"2022","unstructured":"Manuelli V, Pecorari C, Filomeni G, Zito E. Regulation of redox signaling in HIF-1-dependent tumor angiogenesis. FEBS J. 2022;289(18):5413\u201325.","journal-title":"FEBS J"},{"issue":"3","key":"1867_CR22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12026-021-09202-7","volume":"69","author":"M Taghadosi","year":"2021","unstructured":"Taghadosi M, Adib M, Jamshidi A, Mahmoudi M, Farhadi E. The p53 status in rheumatoid arthritis with focus on fibroblast-like synoviocytes. Immunol Res. 2021;69(3):225\u201338.","journal-title":"Immunol Res"},{"issue":"6","key":"1867_CR23","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D","volume":"41","author":"AE Koch","year":"1998","unstructured":"Koch AE. Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 1998;41(6):951\u201362.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1867_CR24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.14.1.34","volume":"14","author":"R Ravi","year":"2000","unstructured":"Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000;14(1):34\u201344.","journal-title":"Genes Dev"},{"issue":"5789","key":"1867_CR25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.1126391","volume":"313","author":"JG Teodoro","year":"2006","unstructured":"Teodoro JG, Parker AE, Zhu X, Green MR. P53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase. Science. 2006;313(5789):968\u201371.","journal-title":"Science"},{"issue":"6","key":"1867_CR26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.tcb.2007.04.004","volume":"17","author":"K Bensaad","year":"2007","unstructured":"Bensaad K, Vousden KH. p53: new roles in metabolism. Trends Cell Biol. 2007;17(6):286\u201391.","journal-title":"Trends Cell Biol"},{"key":"1867_CR27","first-page":"6039769","volume":"2020","author":"X Liu","year":"2020","unstructured":"Liu X, Fan L, Lu C, Yin S, Hu H. Functional role of p53 in the regulation of chemical-induced oxidative stress. Oxid Med Cell Longev. 2020;2020:6039769.","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"1867_CR28","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00109-007-0221-2","volume":"85","author":"JG Teodoro","year":"2007","unstructured":"Teodoro JG, Evans SK, Green MR. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. J Mol Med (Berl). 2007;85(11):1175\u201386.","journal-title":"J Mol Med (Berl)"},{"key":"1867_CR29","first-page":"603","volume":"50","author":"F Zhao","year":"2025","unstructured":"Zhao F, Hu Z, Li G, Liu M, Huang Q, Ai K, et al. Angiogenesis in rheumatoid arthritis: pathological characterization, pathogenic mechanisms, and nano-targeted therapeutic strategies. Bioact Mater. 2025;50:603\u201339.","journal-title":"Bioact Mater"},{"key":"1867_CR30","doi-asserted-by":"crossref","first-page":"1481089","DOI":"10.3389\/fphar.2025.1481089","volume":"16","author":"X Huo","year":"2025","unstructured":"Huo X, Peng Y, Li H, Li C, Liao F, Miao C, et al. The emerging role of vascular endothelial cell-mediated angiogenesis in the imbalance of RA synovial microenvironment and its clinical relevance. Front Pharmacol. 2025;16:1481089.","journal-title":"Front Pharmacol"},{"key":"1867_CR31","doi-asserted-by":"crossref","first-page":"1556359","DOI":"10.3389\/fcell.2025.1556359","volume":"13","author":"X Ye","year":"2025","unstructured":"Ye X, Ren D, Chen Q, Shen J, Wang B, Wu S, et al. Resolution of inflammation during rheumatoid arthritis. Front Cell Dev Biol. 2025;13:1556359.","journal-title":"Front Cell Dev Biol"},{"key":"1867_CR32","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3389\/fimmu.2019.01395","volume":"10","author":"H Yoshitomi","year":"2019","unstructured":"Yoshitomi H. Regulation of immune responses and chronic inflammation by fibroblast-like synoviocytes. Front Immunol. 2019;10:1395.","journal-title":"Front Immunol"},{"key":"1867_CR33","volume":"329","author":"Y Xu","year":"2024","unstructured":"Xu Y, Li S, Wang Y, Pu W, Liu Q, Zhang Y, et al. Fangji Huangqi Decoction alleviates rheumatoid arthritis through regulating HIF-1\u03b1 mediated the angiogenesis and the balance between autophagy and apoptosis. J Ethnopharmacol. 2024;329:118061.","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"1867_CR34","first-page":"345","volume":"21","author":"E Balogh","year":"2019","unstructured":"Balogh E, Biniecka M, Fearon U, Veale DJ, Szekanecz Z. Angiogenesis in inflammatory arthritis. Isr Med Assoc J. 2019;21(5):345\u201352.","journal-title":"Isr Med Assoc J"},{"issue":"suppl 1","key":"1867_CR35","doi-asserted-by":"crossref","first-page":"i65","DOI":"10.1136\/ard.59.suppl_1.i65","volume":"59","author":"AE Koch","year":"2000","unstructured":"Koch AE. The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis. 2000;59(suppl 1):i65\u201371.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1867_CR36","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1007\/s12035-024-04634-2","volume":"62","author":"H Liao","year":"2025","unstructured":"Liao H, Zheng J, Lu J, Shen HL. NF-\u03bab signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential. Mol Neurobiol. 2025;62(6):6998\u20137021.","journal-title":"Mol Neurobiol"},{"key":"1867_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6097417","author":"CM Qui\u00f1onez-Flores","year":"2016","unstructured":"Qui\u00f1onez-Flores CM, Gonz\u00e1lez-Ch\u00e1vez SA, Del R\u00edo N\u00e1jera D, Pacheco-Tena C. Oxidative stress relevance in the pathogenesis of the rheumatoid arthritis: a systematic review. BioMed Res Int. 2016. https:\/\/doi.org\/10.1155\/2016\/6097417.","journal-title":"BioMed Res Int"},{"key":"1867_CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cbi.2017.12.024","volume":"281","author":"A-R Phull","year":"2018","unstructured":"Phull A-R, Nasir B, ul Haq I, Kim SJ. Oxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritis. Chem Biol Interact. 2018;281:121\u201336.","journal-title":"Chem Biol Interact"},{"key":"1867_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7536805","author":"LJSD Fonseca","year":"2019","unstructured":"Fonseca LJSD, Nunes-Souza V, Goulart MOF, Rabelo LA. Oxidative stress in rheumatoid arthritis: what the future might hold regarding novel biomarkers and add-on therapies. Oxid Med Cell Longev. 2019. https:\/\/doi.org\/10.1155\/2019\/7536805.","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"1867_CR40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP. P53 in health and disease. Nat Rev Mol Cell Biol. 2007;8(4):275\u201383.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"1867_CR41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer. 2009;9(10):749\u201358.","journal-title":"Nat Rev Cancer"},{"key":"1867_CR42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","volume":"77","author":"AC Joerger","year":"2008","unstructured":"Joerger AC, Fersht AR. Structural biology of the tumor suppressor p53. Annu Rev Biochem. 2008;77:557\u201382.","journal-title":"Annu Rev Biochem"},{"issue":"10","key":"1867_CR43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nrc1455","volume":"4","author":"AM Bode","year":"2004","unstructured":"Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer. 2004;4(10):793\u2013805.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1867_CR44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","volume":"13","author":"M Wade","year":"2013","unstructured":"Wade M, Li YC, Wahl GM. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer. 2013;13(2):83\u201396.","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"1867_CR45","doi-asserted-by":"crossref","first-page":"15335","DOI":"10.1073\/pnas.93.26.15335","volume":"93","author":"KK Walker","year":"1996","unstructured":"Walker KK, Levine AJ. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci U S A. 1996;93(26):15335\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1867_CR46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrm2395","volume":"9","author":"T Riley","year":"2008","unstructured":"Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol. 2008;9(5):402\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"20","key":"1867_CR47","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1073\/pnas.94.20.10895","volume":"94","author":"GS Firestein","year":"1997","unstructured":"Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A. 1997;94(20):10895\u2013900.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1867_CR48","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar1448","volume":"7","author":"Y Yamanishi","year":"2005","unstructured":"Yamanishi Y, Boyle DL, Green DR, Keystone EC, Connor A, Zollman S, et al. p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis. Arthritis Res Ther. 2005;7(1):R12\u20138.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1867_CR49","first-page":"5581","volume":"12","author":"E Shaulian","year":"1992","unstructured":"Shaulian E, Zauberman A, Ginsberg D, Oren M. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol. 1992;12(12):5581\u201392.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"1867_CR50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nsb0495-321","volume":"2","author":"GM Clore","year":"1995","unstructured":"Clore GM, Ernst J, Clubb R, Omichinski JG, Kennedy WM, Sakaguchi K, et al. Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nat Struct Biol. 1995;2(4):321\u201333.","journal-title":"Nat Struct Biol"},{"issue":"3","key":"1867_CR51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molcel.2006.01.020","volume":"21","author":"CL Brooks","year":"2006","unstructured":"Brooks CL, Gu W. p53 ubiquitination: Mdm2 and beyond. Mol Cell. 2006;21(3):307\u201315.","journal-title":"Mol Cell"},{"key":"1867_CR52","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molimm.2025.06.008","volume":"184","author":"S Ganeshalingam","year":"2025","unstructured":"Ganeshalingam S, Wilson NJ, Ciciriello S, Antonipillai J, Achuthan AA. Cellular interactions in maintaining an inflammatory microenvironment in rheumatoid arthritis. Mol Immunol. 2025;184:112\u201322.","journal-title":"Mol Immunol"},{"issue":"2","key":"1867_CR53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0167-5699(99)01552-2","volume":"21","author":"PP Tak","year":"2000","unstructured":"Tak PP, Zvaifler NJ, Green DR, Firestein GS. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today. 2000;21(2):78\u201382.","journal-title":"Immunol Today"},{"issue":"6","key":"1867_CR54","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/1529-0131(199906)42:6<1088::AID-ANR4>3.0.CO;2-E","volume":"42","author":"Z Han","year":"1999","unstructured":"Han Z, Boyle DL, Shi Y, Green DR, Firestein GS. Dominant-negative p53 mutations in rheumatoid arthritis. Arthritis Rheum. 1999;42(6):1088\u201392.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1867_CR55","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/39.3.262","volume":"39","author":"M Inazuka","year":"2000","unstructured":"Inazuka M, Tahira T, Horiuchi T, Harashima S, Sawabe T, Kondo M, et al. Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium. Rheumatology. 2000;39(3):262\u20136.","journal-title":"Rheumatology"},{"issue":"1","key":"1867_CR56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/nar\/26.1.205","volume":"26","author":"P Hainaut","year":"1998","unstructured":"Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, et al. IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res. 1998;26(1):205\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1867_CR57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2249.1998.00508.x","volume":"111","author":"T R\u00e8me","year":"1998","unstructured":"R\u00e8me T, Travaglio A, Gueydon E, Adla L, Jorgensen C, Sany J. Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue. Clin Exp Immunol. 1998;111(2):353\u20138.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1867_CR58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0002-9440(10)65302-3","volume":"154","author":"A Leri","year":"1999","unstructured":"Leri A, Liu Y, Claudio PP, Kajstura J, Wang X, Wang S, et al. Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin\u2013angiotensin system and stretch-mediated apoptosis. Am J Pathol. 1999;154(2):567\u201380.","journal-title":"Am J Pathol"},{"issue":"10","key":"1867_CR59","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/1529-0131(199810)41:10<1772::AID-ART9>3.0.CO;2-C","volume":"41","author":"JL Cannons","year":"1998","unstructured":"Cannons JL, Karsh J, Birnboim HC, Goldstein R. HPRT\u2013mutant T cells in the peripheral blood and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 1998;41(10):1772\u201382.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1867_CR60","first-page":"1091","volume":"152","author":"KR Aupperle","year":"1998","unstructured":"Aupperle KR, Boyle DL, Hendrix M, Seftor EA, Zvaifler NJ, Barbosa M, et al. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol. 1998;152(4):1091.","journal-title":"Am J Pathol"},{"issue":"3","key":"1867_CR61","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/1529-0131(200103)44:3<676::AID-ANR117>3.0.CO;2-6","volume":"44","author":"T Pap","year":"2001","unstructured":"Pap T, Aupperle KR, Gay S, Firestein GS, Gay RE. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis Rheum. 2001;44(3):676\u201381.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1867_CR62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1297-319X(03)00088-5","volume":"70","author":"G Clavel","year":"2003","unstructured":"Clavel G, Bessis N, Boissier M-C. Recent data on the role for angiogenesis in rheumatoid arthritis. Joint Bone Spine. 2003;70(5):321\u20136.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"1867_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0049-0172(82)90020-8","volume":"12","author":"BM Rothschild","year":"1982","unstructured":"Rothschild BM, Masi AT. Pathogenesis of rheumatoid arthritis: a vascular hypothesis. Semin Arthritis Rheum. 1982;12(1):11\u201331. https:\/\/doi.org\/10.1016\/0049-0172(82)90020-8.","journal-title":"Semin Arthritis Rheum"},{"key":"1867_CR64","volume":"910","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wu H, Deng R. Angiogenesis as a potential treatment strategy for rheumatoid arthritis. Eur J Pharmacol. 2021;910:174500.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1867_CR65","first-page":"75","volume":"1","author":"M Mumtaz","year":"2020","unstructured":"Mumtaz M, Hussain N. Rheumatoid arthritis and the role of VEGF gene: an overview. J Sci Res Med Biol Sci. 2020;1(2):75\u201390.","journal-title":"J Sci Res Med Biol Sci"},{"issue":"1","key":"1867_CR66","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2249.1999.00775.x","volume":"115","author":"B Berse","year":"1999","unstructured":"Berse B, Hunt JA, Diegel RJ, Morganelli P, Yeo K, Brown F, et al. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol. 1999;115(1):176\u201382.","journal-title":"Clin Exp Immunol"},{"key":"1867_CR67","first-page":"4375120","volume":"2016","author":"MA Rahat","year":"2016","unstructured":"Rahat MA, Shakya J. Parallel aspects of the microenvironment in cancer and autoimmune disease. Mediators Inflamm. 2016;2016:4375120.","journal-title":"Mediators Inflamm"},{"issue":"18","key":"1867_CR68","first-page":"6952","volume":"61","author":"S Pal","year":"2001","unstructured":"Pal S, Datta K, Mukhopadhyay D. Central role of p53 on regulation of vascular permeability factor\/vascular endothelial growth factor (VPF\/VEGF) expression in mammary carcinoma. Cancer Res. 2001;61(18):6952\u20137.","journal-title":"Cancer Res"},{"issue":"13","key":"1867_CR69","first-page":"3655","volume":"60","author":"L Zhang","year":"2000","unstructured":"Zhang L, Yu D, Hu M, Xiong S, Lang A, Ellis LM, et al. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Can Res. 2000;60(13):3655\u201361.","journal-title":"Can Res"},{"issue":"18","key":"1867_CR70","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/1873-3468.13525","volume":"593","author":"P Wang","year":"2019","unstructured":"Wang P, Guan D, Zhang XP, Liu F, Wang W. Modeling the regulation of p53 activation by HIF-1 upon hypoxia. FEBS Lett. 2019;593(18):2596\u2013611.","journal-title":"FEBS Lett"},{"issue":"6","key":"1867_CR71","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2174\/1389450111314060010","volume":"14","author":"X Zhao","year":"2013","unstructured":"Zhao X, Yue Y, Cheng W, Li J, Hu Y, Qin L, et al. Hypoxia-inducible factor: a potential therapeutic target for rheumatoid arthritis. Curr Drug Targets. 2013;14(6):700\u20137.","journal-title":"Curr Drug Targets"},{"issue":"1","key":"1867_CR72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.14.1.34","volume":"14","author":"R Ravi","year":"2000","unstructured":"Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1\u03b1. Genes Dev. 2000;14(1):34\u201344.","journal-title":"Genes Dev"},{"issue":"5","key":"1867_CR73","volume":"3","author":"S Oda","year":"2008","unstructured":"Oda S, Oda T, Nishi K, Takabuchi S, Wakamatsu T, Tanaka T, et al. Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS ONE. 2008;3(5):e2215.","journal-title":"PLoS ONE"},{"issue":"1","key":"1867_CR74","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s11033-025-10769-9","volume":"52","author":"SS Hassani","year":"2025","unstructured":"Hassani SS, Farhadi E, Esmaeili SA, Mahmoudi M, Mahmoudi M, Afshari JT, et al. Deciphering the role of ERK and PI3K\/Akt as crosstalk pathways between fibroblast-like synoviocytes and osteoclasts; novel therapeutic approach for rheumatoid arthritis. Mol Biol Rep. 2025;52(1):662.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"1867_CR75","volume":"8","author":"Q Ding","year":"2023","unstructured":"Ding Q, Hu W, Wang R, Yang Q, Zhu M, Li M, et al. Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther. 2023;8(1):68.","journal-title":"Signal Transduct Target Ther"},{"key":"1867_CR76","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijsu.2015.04.050","volume":"20","author":"R Song","year":"2015","unstructured":"Song R, Tian K, Wang W, Wang L. P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K\/AKT\/mTOR pathway. Int J Surg. 2015;20:80\u20137.","journal-title":"Int J Surg"},{"issue":"22","key":"1867_CR77","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.1158\/0008-5472.CAN-06-0999","volume":"66","author":"PY Zeng","year":"2006","unstructured":"Zeng PY, Berger SL. LKB1 is recruited to the p21\/WAF1 promoter by p53 to mediate transcriptional activation. Cancer Res. 2006;66(22):10701\u20138.","journal-title":"Cancer Res"},{"issue":"3","key":"1867_CR78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","volume":"12","author":"A Perl","year":"2016","unstructured":"Perl A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol. 2016;12(3):169\u201382.","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"1867_CR79","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","volume":"67","author":"Z Feng","year":"2007","unstructured":"Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, et al. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 2007;67(7):3043\u201353.","journal-title":"Cancer Res"},{"issue":"9","key":"1867_CR80","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 2011;13(9):1016\u201323.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"1867_CR81","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.15287","volume":"27","author":"F Qiang","year":"2024","unstructured":"Qiang F, Xuan D, Liu J, Sheng J. Knockdown of NFIL3 modulates the AMPK pathway to suppress excessive cell proliferation, inflammation, and migration in rheumatoid arthritis. Int J Rheum Dis. 2024;27(8):e15287.","journal-title":"Int J Rheum Dis"},{"key":"1867_CR82","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Dang J, Lin X, Wang M, Liu Y, Chen J, et al. RA Fibroblast-like synoviocytes derived extracellular vesicles promote angiogenesis by miRNA-1972 targeting p53\/mTOR signaling in vascular endotheliocyte. Front Immunol. 2022;13:793855.","journal-title":"Front Immunol"},{"issue":"1","key":"1867_CR83","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13075-019-1861-7","volume":"21","author":"S Yu","year":"2019","unstructured":"Yu S, Lu Y, Zong M, Tan Q, Fan L. Hypoxia-induced miR-191-C\/EBP\u03b2 signaling regulates cell proliferation and apoptosis of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):78.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1867_CR84","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/hep.29116","volume":"66","author":"H Li","year":"2017","unstructured":"Li H, Zhou ZQ, Yang ZR, Tong DN, Guan J, Shi BJ, et al. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma. Hepatology. 2017;66(1):136\u201351.","journal-title":"Hepatology"},{"issue":"5178","key":"1867_CR85","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.7521539","volume":"265","author":"KM Dameron","year":"1994","unstructured":"Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 1994;265(5178):1582\u20134.","journal-title":"Science"},{"issue":"5","key":"1867_CR86","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1590\/S0100-879X1999000500011","volume":"32","author":"DG Stupack","year":"1999","unstructured":"Stupack DG, Storgard CM, Cheresh DA. A role for angiogenesis in rheumatoid arthritis. Braz J Med Biol Res. 1999;32(5):573\u201381.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"1867_CR87","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI3756","volume":"103","author":"CM Storgard","year":"1999","unstructured":"Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA. Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest. 1999;103(1):47\u201354.","journal-title":"J Clin Invest"},{"issue":"2","key":"1867_CR88","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1172\/JCI118808","volume":"98","author":"S Str\u00f6mblad","year":"1996","unstructured":"Str\u00f6mblad S, Becker JC, Yebra M, Brooks PC, Cheresh DA. Suppression of p53 activity and p21WAF1\/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. J Clin Invest. 1996;98(2):426\u201333.","journal-title":"J Clin Invest"},{"issue":"7","key":"1867_CR89","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","volume":"79","author":"PC Brooks","year":"1994","unstructured":"Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79(7):1157\u201364.","journal-title":"Cell"},{"key":"1867_CR90","doi-asserted-by":"crossref","unstructured":"Morshed A, Abbas AB, Hu J, Xu H. Shedding New Light on The Role of \u03b1\u03bd\u03b23 and \u03b15\u03b21 Integrins in Rheumatoid Arthritis. Molecules. 2019;24(8).","DOI":"10.3390\/molecules24081537"},{"issue":"4","key":"1867_CR91","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.141.4.1083","volume":"141","author":"M Scatena","year":"1998","unstructured":"Scatena M, Almeida M, Chaisson ML, Fausto N, Nicosia RF, Giachelli CM. NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol. 1998;141(4):1083\u201393.","journal-title":"J Cell Biol"},{"issue":"Suppl 2","key":"1867_CR92","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/ard.61.suppl_2.ii96","volume":"61","author":"RL Wilder","year":"2002","unstructured":"Wilder RL. Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis. 2002;61(Suppl 2):96\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1867_CR93","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tem.2014.06.012","volume":"25","author":"GR Drummond","year":"2014","unstructured":"Drummond GR, Sobey CG. Endothelial NADPH oxidases: which NOX to target in vascular disease? Trends Endocrinol Metab. 2014;25(9):452\u201363.","journal-title":"Trends Endocrinol Metab"},{"key":"1867_CR94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.freeradbiomed.2023.02.012","volume":"199","author":"HE Boudreau","year":"2023","unstructured":"Boudreau HE, Korzeniowska A, Leto TL. Mutant p53 and NOX4 are modulators of a CCL5-driven pro-migratory secretome. Free Radic Biol Med. 2023;199:17\u201325.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1867_CR95","doi-asserted-by":"crossref","first-page":"89","DOI":"10.59566\/IJBS.2008.4089","volume":"4","author":"LA Pham-Huy","year":"2008","unstructured":"Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci: IJBS. 2008;4(2):89.","journal-title":"Int J Biomed Sci: IJBS"},{"issue":"2","key":"1867_CR96","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","volume":"48","author":"LA Sena","year":"2012","unstructured":"Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012;48(2):158\u201367.","journal-title":"Mol Cell"},{"key":"1867_CR97","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00418-004-0679-8","volume":"122","author":"WM Nauseef","year":"2004","unstructured":"Nauseef WM. Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol. 2004;122:277\u201391.","journal-title":"Histochem Cell Biol"},{"issue":"8","key":"1867_CR98","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/art.30395","volume":"63","author":"M Biniecka","year":"2011","unstructured":"Biniecka M, Fox E, Gao W, Ng CT, Veale DJ, Fearon U, et al. Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis. Arthritis Rheum. 2011;63(8):2172\u201382.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1867_CR99","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2004.06.008","volume":"213","author":"S Dupont","year":"2004","unstructured":"Dupont S, Zacchigna L, Adorno M, Soligo S, Volpin D, Piccolo S, et al. Convergence of p53 and TGF-beta signaling networks. Cancer Lett. 2004;213(2):129\u201338.","journal-title":"Cancer Lett"},{"issue":"4","key":"1867_CR100","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/jcp.24229","volume":"228","author":"S Term\u00e9n","year":"2013","unstructured":"Term\u00e9n S, Tan EJ, Heldin CH, Moustakas A. p53 regulates epithelial\u2013mesenchymal transition induced by transforming growth factor \u03b2. J Cell Physiol. 2013;228(4):801\u201313.","journal-title":"J Cell Physiol"},{"issue":"6","key":"1867_CR101","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.20082251","volume":"206","author":"L Shao","year":"2009","unstructured":"Shao L, Fujii H, Colmegna I, Oishi H, Goronzy JJ, Weyand CM. Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J Exp Med. 2009;206(6):1435\u201349.","journal-title":"J Exp Med"},{"issue":"6","key":"1867_CR102","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4078\/jrd.2016.23.6.340","volume":"23","author":"S-J Yoo","year":"2016","unstructured":"Yoo S-J, Go E, Kim Y-E, Lee S, Kwon J. Roles of reactive oxygen species in rheumatoid arthritis pathogenesis. J Rheum Dis. 2016;23(6):340\u20137.","journal-title":"J Rheum Dis"},{"issue":"5","key":"1867_CR103","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/ar2803","volume":"11","author":"WB van den Berg","year":"2009","unstructured":"van den Berg WB. Lessons from animal models of arthritis over the past decade. Arthr Res Ther. 2009;11(5):250.","journal-title":"Arthr Res Ther"},{"key":"1867_CR104","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.freeradbiomed.2012.11.006","volume":"57","author":"P Eggleton","year":"2013","unstructured":"Eggleton P, Nissim A, Ryan BJ, Whiteman M, Winyard PG. Detection and isolation of human serum autoantibodies that recognize oxidatively modified autoantigens. Free Radic Biol Med. 2013;57:79\u201391.","journal-title":"Free Radic Biol Med"},{"key":"1867_CR105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2021.06.013","volume":"172","author":"T Shi","year":"2021","unstructured":"Shi T, van Soest DMK, Polderman PE, Burgering BMT, Dansen TB. DNA damage and oxidant stress activate p53 through differential upstream signaling pathways. Free Radic Biol Med. 2021;172:298\u2013311.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1867_CR106","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3390\/biom10030361","volume":"10","author":"M Cordani","year":"2020","unstructured":"Cordani M, Butera G, Pacchiana R, Masetto F, Mullappilly N, Riganti C, et al. Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells. Biomolecules. 2020;10(3):361.","journal-title":"Biomolecules"},{"issue":"21","key":"1867_CR107","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1073\/pnas.93.21.11848","volume":"93","author":"TM Johnson","year":"1996","unstructured":"Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci U S A. 1996;93(21):11848\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1867_CR108","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.freeradbiomed.2023.07.022","volume":"207","author":"S Rius-P\u00e9rez","year":"2023","unstructured":"Rius-P\u00e9rez S. p53 at the crossroad between mitochondrial reactive oxygen species and necroptosis. Free Radic Biol Med. 2023;207:183\u201393.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1867_CR109","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","volume":"22","author":"C Cant\u00f3","year":"2015","unstructured":"Cant\u00f3 C, Menzies KJ, Auwerx J. NAD(+) Metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 2015;22(1):31\u201353.","journal-title":"Cell Metab"},{"issue":"7","key":"1867_CR110","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/annrheumdis-2020-217377","volume":"79","author":"A Leblond","year":"2020","unstructured":"Leblond A, Pezet S, Cauvet A, Casas C, Pires Da Silva J, Herv\u00e9 R, et al. Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis. Ann Rheum Dis. 2020;79(7):891\u2013900.","journal-title":"Ann Rheum Dis"},{"issue":"5666","key":"1867_CR111","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.1094637","volume":"303","author":"A Brunet","year":"2004","unstructured":"Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004;303(5666):2011\u20135.","journal-title":"Science"},{"issue":"2","key":"1867_CR112","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/ijms24021532","volume":"24","author":"A Poniewierska-Baran","year":"2023","unstructured":"Poniewierska-Baran A, Bochniak O, Warias P, Pawlik A. Role of sirtuins in the pathogenesis of rheumatoid arthritis. Int J Mol Sci. 2023;24(2):1532.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1867_CR113","doi-asserted-by":"crossref","first-page":"20180541","DOI":"10.1042\/BSR20180541","volume":"38","author":"G Li","year":"2018","unstructured":"Li G, Xia Z, Liu Y, Meng F, Wu X, Fang Y, et al. SIRT1 inhibits rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and inflammatory response via suppressing NF-\u03baB pathway. Biosci Rep. 2018;38(3):20180541.","journal-title":"Biosci Rep"},{"key":"1867_CR114","doi-asserted-by":"crossref","first-page":"7543973","DOI":"10.1155\/2017\/7543973","volume":"2017","author":"W Zhang","year":"2017","unstructured":"Zhang W, Huang Q, Zeng Z, Wu J, Zhang Y, Chen Z. Sirt1 inhibits oxidative stress in vascular endothelial cells. Oxid Med Cell Longev. 2017;2017:7543973.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"1867_CR115","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.3390\/ijms14023834","volume":"14","author":"A Salminen","year":"2013","unstructured":"Salminen A, Kaarniranta K, Kauppinen A. Crosstalk between oxidative stress and SIRT1: impact on the aging process. Int J Mol Sci. 2013;14(2):3834\u201359.","journal-title":"Int J Mol Sci"},{"key":"1867_CR116","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/annrheumdis-2017-eular.1501","volume":"76","author":"S Subesinghe","year":"2017","unstructured":"Subesinghe S, Rutherford A, Byng-Maddick R, Galloway J. OP0153 recurrent infections in rheumatoid arthritis patients, results from the bsrbr. Ann Rheum Dis. 2017;76:115\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6B","key":"1867_CR117","first-page":"3415","volume":"16","author":"FR Spitz","year":"1996","unstructured":"Spitz FR, Nguyen D, Skibber JM, Cusack J, Roth JA, Cristiano RJ. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. Anticancer Res. 1996;16(6B):3415\u201322.","journal-title":"Anticancer Res"},{"issue":"4","key":"1867_CR118","doi-asserted-by":"crossref","first-page":"e2003193118","DOI":"10.1073\/pnas.2003193118","volume":"118","author":"L Chibaya","year":"2021","unstructured":"Chibaya L, Karim B, Zhang H, Jones SN. Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis. Proc Natl Acad Sci USA. 2021;118(4):e2003193118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"1867_CR119","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.20.02341","volume":"39","author":"DA Sallman","year":"2021","unstructured":"Sallman DA, DeZern AE, Garcia-Manero G, Steensma DP, Roboz GJ, Sekeres MA, et al. Eprenetapopt (APR-246) and azacitidine in TP53-mutant myelodysplastic syndromes. J Clin Oncol. 2021;39(14):1584\u201394.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1867_CR120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/cancers13040748","volume":"13","author":"H Pasquer","year":"2021","unstructured":"Pasquer H, Tostain M, Kaci N, Roux B, Benajiba L. Descriptive and functional genomics in acute myeloid leukemia (AML): paving the road for a cure. Cancers. 2021;13(4):748.","journal-title":"Cancers"},{"issue":"9","key":"1867_CR121","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.exphem.2016.05.014","volume":"44","author":"K Kojima","year":"2016","unstructured":"Kojima K, Ishizawa J, Andreeff M. Pharmacological activation of wild-type p53 in the therapy of leukemia. Exp Hematol. 2016;44(9):791\u20138.","journal-title":"Exp Hematol"},{"issue":"4","key":"1867_CR122","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/jcmm.17649","volume":"27","author":"VJ Thannickal","year":"2023","unstructured":"Thannickal VJ, Jandeleit-Dahm K, Szyndralewiez C, T\u00f6r\u00f6k NJ. Pre-clinical evidence of a dual NADPH oxidase 1\/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis. J Cell Mol Med. 2023;27(4):471\u201381.","journal-title":"J Cell Mol Med"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01867-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01867-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01867-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:48:00Z","timestamp":1764917280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01867-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1867"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01867-w","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"322"}}